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Using the shape parameters for the 3D bone surfaces of the two groups,
the characteristic differences between the groups are estimated using
Linear Discriminant Analysis (LDA), which ﬁnds the vector that best
separates the groups. The shape differences were visualized by moving
between the means of the groups along the discriminant vector. Permu-
tation tests were used to determine the signiﬁcance of the separation
between the groups. For a large number of permutations the examples
were randomly labelled as progressors or non-progressors. The statis-
tical distance normalized by variance (the true Mahalanobis distance)
between the group means was compared with a distribution taken from
the permutation tests and reported as a p value.
Results: The p-value can be understood as the probability that a vector
at least as discriminating could have occurred by chance. The p-value for
the tibial vector was 0.03, and for the femur was 0.01, indicating that the
vectors chosen were genuinely discriminating.
These vectors can be visualized, and are illustrated in Figures 1 to 3.
Changes were observed in the medial tibial plateau, the lateral tibial
plateau, the patellofemoral joint, and the articulating surface of the femoral
condyles.
Figure 1. Visualization of vector from progression group to non-
progression group on the femur bone. To illustrate changes, outline from
“No-progression” is projected onto “Progression”. Progression group is
characterized by wider patella-femoral joint, wider notch and differing
angle of femur which articulates with tibia.
Figure 2. Visualization of vector on the medial tibial plateau. To illustrate
changes, outline from “No-progression” is projected onto “Progression”.
Progression group is characterized by ﬂatter surface and forms less of
a dish shape than the non-progression group. This may denote a less
stable joint within the progression group.
Figure 3. Visualization of vector on the lateral tibial plateau. In the
progression group, the lateral condyle slopes down towards the lateral
edge of the tibia. This may also help to create a knee joint which is less
stable than that within the non-progression group.
Conclusions: Statistical models were able to demonstrate signiﬁcant
3D shape differences in the tibia and femur between the groups. These
results were produced on comparatively small datasets, and it is important
to repeat this work using larger datasets, and different methods of
measuring progression to conﬁrm the results.
Statistical modelling of shape provides a useful tool for hypothesis gen-
eration, and can be used on other groups to study OA progression. For
example, the method could be used to compare subjects with and without
pain, or who progress based on K/L or WOMAC scores.
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Purpose: Joint bleeds occur frequently in patients suffering from
haemophilia or can occur as a consequence of joint trauma. Even a
limited number of bleeds has been demonstrated to lead to severe
joint damage in time. With respect to the mechanisms of blood induced
joint damage, we have demonstrated that monocytes/macrophages within
the mononuclear cell population together with the red blood cells as
present in blood are responsible for the irreversible inhibition of car-
tilage matrix synthesis. Small amounts of Il-1 that are produced by
activated monocytes/macrophages increase the production of hydrogen
peroxide (H2O2) by chondrocytes. The hydrogen peroxide reacts with
haemoglobin-derived iron from damaged and phagocytosed red blood
cells, which results in the formation of hydroxyl radicals in the vicinity
of chondrocytes. This leads to chondrocyte apoptosis and with that
the irreversible inhibition of cartilage matrix synthesis. In this study, we
investigated whether the immunoregulatory cytokine interleukin-10 (Il-10)
can prevent or limit this blood-induced joint damage.
Methods: Healthy human articular cartilage tissue explants were cultured
in the presence or absence of 50% v/v blood for 4 days, followed by
a recovery period of 12 days. Il-10 was added in 1 or 10 ng/ml. Also
cartilage and synovium in case of haemophilic arthropathy (frequently
exposed to blood in vivo over a long period of time), obtained at joint
replacement surgery, was cultured in the presence of Il-10 (10 ng/ml).
The effect on cartilage matrix proteoglycan synthesis, -release, and -
content were determined as well as the Il-1b and TNFa production by the
synovium.
Results: Il-10 was able to prevent the decrease in proteoglycan syn-
thesis and the increase in proteoglycan release of cartilage exposed
to blood dose dependently (p< 0.05). As a consequence, the decrease
in proteoglycan content after blood exposure could be prevented dose
dependently (p< 0.05). With 10 ng/ml Il-10, which is still a low dose for
local therapeutic treatment, at least 50% reduction in adverse effects
was observed (p< 0.05). The signiﬁcantly disturbed matrix turnover of
haemophilic cartilage improved upon addition of Il-10 and also the pro-
duction of Il-1b and TNFa by haemophilic synovium decreased in the
presence of Il-10 (all p< 0.05).
Conclusions: The present results show that interleukin-10 prevents the
direct harmful effects of blood on articular cartilage and has a ben-
eﬁcial effect on the matrix turnover of haemophilic cartilage and pro-
inﬂammatory cytokine production by haemophilic synovium. Therefore,
although Il-10 was not effective in systemic treatment of rheumatoid
arthritis, it might be worthwhile to test Il-10 in more detail as a therapeutic
option for local treatment of joint haemorrhages, to prevent joint damage
in time.
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Purpose: Macrophages might play an important role in the development
of osteoarthritis (OA) for they can produce a large variety of enzymes
and pro-inﬂammatory cytokines. These mediators are known to have
pathogenic and destructive effects on all joint tissues. Thus evaluation
of macrophage action may provide essential information about etiology
as well as progression rate of osteoarthritis. Once active, macrophages
abundantly express the functional form of the folate-receptor-beta (FR-b),
which binds the vitamin folic acid with high afﬁnity. By targeting the FR-b
using radioactive labeled folic acid, one can image macrophage activity
in-vivo in real-time. The purpose of this study is to image and monitor
macrophage activity in experimental OA.
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Methods: Animal models: experimental OA was induced in male Wistar
rats by intra-articular injection of 3mg mono-iodoacetate (MIA) into the
right knee, the left knee served as a control and was injected with
saline (biochemical model, n = 4); A second OA model was used to
verify model speciﬁc macrophage activity, we used the surgical anterior
ligament transection model (ACLT, n = 2). As a positive control, we used a
rheumatoid arthritis (RA) mouse model in which RA was induced into the
right knee by injection of methylated bovine serum albumin (mBSA) after
immunisation (n = 2). In this RA model, activated macrophages are known
to be involved abundantly. 24 hours prior to imaging animals we injected
with radioactive labeled folic acid (111In-DOTA-FA). Images of the animals
were obtained using a dedicated small animal multipinhole SPECT/CT
camera (nano-SPECT/CT, Bioscan inc.). Images were obtained at 3, 27
and 52 days after OA induction.
Results: All three models (RA, ACLT, MIA) showed increased uptake of
the 111In-DOTA-FA, not only in the synovial region of the knee, but also
in the plopliteal and inguinal lymph node regions at 15 27 and 52 days.
However, the uptake of activity was less in the experimental OA models
than in the RA model. The MIA model showed a higher activity rate in the
lymph node regions than was seen in the ACLT-model, in which activated
macrophages seemed to play a more prominent role in the synovium.
(a−d) MPH-SPECT/CT images of a RA-mouse (a) and OA rats (b,c =MIA,
d =ACLT) in frontal plane 3D (a,b) and sagittal plane 2D (c,d). Note the
excess activation of macrophages in the lymphoid tissue in the RA mouse
and less in the MIA rat (red arrows) and the activation in the synovial
tissue (white arrow). The SPECT image is represented in color, the micro-
CT image is in grey.
Conclusions: Macrophage activation in experimental OA could clearly
be monitored by SPECT/CT in combination with a folate tracer. As
expected we found increased activation around the knee area, probably
the synovium, though the amount of activity of macrophages in the
lymphoid system up to the inguinal nodes in experimental OA was not
as expected. This shows that macrophages play not only a local role but
are also involved in a more systemic response to the affected knee. This
response is known in RA, in which macrophages have a (auto-)antigen
presenting role in the lymph-nodes. Though, such a role for OA is not
known. By investigating a surgical as well as a biochemical OA-model
it becomes less likely that there is a direct response of macrophages to
the speciﬁc models, as lymph-node activation was high in both models
till the end of the experiment (7.5 wks). To conclude, in-vivo visualization
of activated macrophages in OA provides more insight in OA etiology,
enables to monitor OA intervention strategies and provides a new imaging
biomarker.
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Purpose: Matrix metalloproteases (MMPs) are thought to be important
factors that mediate cartilage loss in osteoarthritis (OA). Il-1 is a strong
inducer of chondrocyte MMP expression however, a role for Il-1 in OA has
never been clearly demonstrated; therefore other factors may play a roll
in regulating MMP expression and cartilage remodeling. Polymorphisms
identiﬁed in genes from the wnt/b-catenin pathway have been associated
with OA and recently, we found that wnt1-inducible secreted protein-1
(WISP1) was expressed at high levels during experimental OA. The aim of
the present study was to examine WISP1 expression in human OA tissue
and to determine the potential of WISP1 to cause cartilage degradation
independently of Il-1.
Methods: Expression of WISP1, both in human OA synovium and
cartilage was determined by Q-PCR and by immunohistochemistry. To
study the effect of WISP1 on cells we stimulated macrophages and
chondrocytes with recombinant WISP1and assayed the effect on the
induction of cartilage degrading enzymes. An adenoviral vector for WISP1
overexpression was generated, and injected in the murine knee joint of
either control mice or Il-1−/− mice. Subsequently, markers for cartilage
degradation were determined.
Results: WISP1 expression in human tissue was 3 times higher in OA
synovium and over 2 times higher in cartilage, compared to control tissue.
In cartilage of OA patients there was clear expression of WISP1 in
chondrocytes and also located pericellularly in the adjacent extracellular
matrix. WISP1 was not detected in control (post-mortem) cartilage. Stimu-
lation of macrophages with WISP1 for 24 hours resulted in the induction of
MMP-3, MMP-9 and MMP-13, 8-, 5- and 3-fold respectively. Remarkably,
no Il-1 was induced by WISP1. In chondrocytes and ﬁbroblasts, only
MMP-3 was signiﬁcantly induced. Synovial overexpression of WISP1
following WISP1-expressing adenovirus injection into murine knee joints
resulted in strong induction of MMP3, MMP-9, MMP-13, ADAMTS4 and
ADAMTS5 in the synovium (12-, 8-, 2-, 10- and 2-fold), and of MMP-3,
MMP-13 and ADAMTS4 in the cartilage (100-, 12, and 3-fold). Neo-
epitope markers for enzymatic cartilage damage, VDIPEN (MMPs) and
NITEGE (aggrecanases) were signiﬁcantly induced in knee joints, 4 days
after WISP1 overexpression. Control virus did not induce any markers
for cartilage degradation. Interestingly, cartilage damage and expression
of catabolic enzymes were identical in Il-1−/− and wild type mice after
WISP1 overexpression, indicating that WISP1 induces cartilage damage
independently of Il-1.
Conclusions:WISP1 is expressed in human OA synovium and cartilage,
and levels are higher compared to controls. WISP1 is a potent inducer
of several MMPs and overexpression causes cartilage degradation. This
effect on cartilage damage is independent of Il-1. We have identiﬁed a
novel mechanism that may contribute to cartilage loss in OA that works
independently of Il-1.
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Purpose: Chondroitin sulfate (CS) is a natural glycosaminoglycan, cur-
rently employed in osteoarthritis, with a therapeutic effect that has been
partially attributed to a potential antiinﬂammatory action on joint cells. We
have previously reported that CS was capable to reduce the markers of
vascular and systemic inﬂammation in rabbits with a combined model of
aterosclerosis and chronic arthritis (British J Pharmacol, 2008). In this
work, our aim was to explore the effect of the administration of CS on
the sinovial injury and on markers of synovial inﬂammation in rabbits with
this combined model and in synovial cells in culture.
Methods: Chronic arthritis was induced by repeated intraarticular in-
jections of ovalbumin in previously immunized rabbits. Atherosclerosis
was simultaneously induced in these rabbits by maintaining them on a
hyperlipidemic diet after producing a femoral de-endothelization. A group
of these rabbits were treated
prophylactically with CS (100mg/kg/day). At sacriﬁce, pheripheral blood
mononuclear cells (PBMC) and synovial membranes were isolated and
stored for expression studies. A piece of synovial membrane was embed-
ded in parafﬁn for histological examination. In order to study the possible
mechanism of action of CS, we also employed human synovial ﬁbroblast
in culture stimulated with Il-1b in the presence or absence of CS (2mM).
Results: In the PBMC from rabbits with the combined model, CS inhib-
ited the expression of monocyte chemoattractant protein (MCP)-1 and
cyclooxigenase (COX)-2 (determined by quantitative PCR and western
blot) and the activation of the NFkB (studied by mobility shift assay). In
the synovial membrane, CS signiﬁcantly diminished the gene expression
and the protein synthesis of COX-2 and MCP-1 and the histopathological
synovitis score (Krenn scale) in comparison to untreated rabbits. In
fact, in the synovial membrane CS partially prevented the intimal layer
proliferation and the inﬂammatory cell inﬁltration observed in the non-
treated animals. Moreover, in synovial cells in culture, CS presence was
able to inhibit the NFkB activation induced by Il-1b.
